Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.48 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.45 |
| ▸ | PPARG | P37231 | 7/20 | 0.45 |
| ▸ | PPARD | Q03181 | 7/20 | 0.45 |
| ▸ | PPARA | Q07869 | 7/20 | 0.45 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.45 |
| ▸ | TSHR | P16473 | 4/20 | 0.45 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | TLR2 | O60603 | 2/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.45 |
| ▸ | FABP4 | P15090 | 2/20 | 0.45 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.45 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | ESR1 | P03372 | 1/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.45 |
| ▸ | PDE4A | P27815 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4397729 | 1.00 | FFAR4 (0.48) | FFAR4FFAR1LMNAGPR84PPARG | |
| SCHEMBL17654948 | 0.93 | FFAR4 (0.42) | FFAR4FFAR1LMNAGPR84PPARG | |
| SCHEMBL15216433 | 0.90 | CA12 (0.46) | LMNAPPARGPPARAALDH1A1MAPT | |
| SCHEMBL17654946 | 0.86 | LMNA (0.53) | LMNATSHRALDH1A1MEN1KMT2A | |
| SCHEMBL15198293 | 0.86 | ALDH1A1 (0.49) | FFAR4FFAR1LMNAPPARGPPARD | |
| SCHEMBL24882733 | 0.84 | FFAR4 (0.61) | FFAR4FFAR1LMNAGPR84PPARG | |
| SCHEMBL4414339 | 0.84 | FFAR4 (0.61) | FFAR4FFAR1LMNAGPR84PPARG | |
| SCHEMBL4410097 | 0.84 | FFAR4 (0.61) | FFAR4FFAR1LMNAGPR84PPARG | |
| SCHEMBL4405746 | 0.84 | FFAR4 (0.61) | FFAR4FFAR1LMNAGPR84PPARG | |
| SCHEMBL15217202 | 0.83 | CA12 (0.47) | LMNAPPARGPPARAALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170211016-A1 | SYNERGISTIC SURFACTANT BLENDS | STEPAN CO (US) | 2017-07-27 | — | — | US | disclosed |
| US-20170211016-A1 | SYNERGISTIC SURFACTANT BLENDS | STEPAN CO (US) | 2017-07-27 | — | — | US | disclosed |
| US-9688944-B2 | Synergistic surfactant blends | STEPAN COMPANY (US) | 2017-06-27 | — | — | US | disclosed |
| US-9688944-B2 | Synergistic surfactant blends | STEPAN COMPANY (US) | 2017-06-27 | — | — | US | disclosed |
| US-9598359-B2 | Sulfonates from natural oil metathesis | STEPAN COMPANY (US) | 2017-03-21 | — | — | US | disclosed |
| US-9598359-B2 | Sulfonates from natural oil metathesis | STEPAN COMPANY (US) | 2017-03-21 | — | — | US | disclosed |
| US-9303234-B2 | Hard surface cleaners based on compositions derived from natural oil metathesis | STEPAN COMPANY (US) | 2016-04-05 | — | — | US | disclosed |
| US-20150094383-A1 | SYNERGISTIC SURFACTANT BLENDS | STEPAN CO (US) | 2015-04-02 | — | — | US | disclosed |
| US-20150094383-A1 | SYNERGISTIC SURFACTANT BLENDS | STEPAN CO (US) | 2015-04-02 | — | — | US | disclosed |
| WO-2013162924-A1 | SYNERGISTIC SURFACTANT BLENDS | STEPAN COMPANY (US) | 2013-10-31 | — | — | WO | disclosed |
| US-20130225473-A1 | SULFONATES FROM NATURAL OIL METATHESIS | STEPAN COMPANY (US) | 2013-08-29 | — | — | US | disclosed |
| US-20130225473-A1 | SULFONATES FROM NATURAL OIL METATHESIS | STEPAN COMPANY (US) | 2013-08-29 | — | — | US | disclosed |
| US-20130225469-A1 | HARD SURFACE CLEANERS BASED ON COMPOSITIONS DERIVED FROM NATURAL OIL METATHESIS | STEPAN COMPANY (US) | 2013-08-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130225473-A1 | SULFONATES FROM NATURAL OIL METATHESIS | STS, SULT1E1, SULT1A1 | FFAR4 238/4885FFAR1 38/4885LMNA 4164/4885 |
| US-20150094383-A1 | SYNERGISTIC SURFACTANT BLENDS | HHAT, AADAT, SQLE | FFAR4 100/4885FFAR1 51/4885LMNA 2279/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.